These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 24070190)
21. Identification of interleukin-26 in the dromedary camel (Camelus dromedarius): Evidence of alternative splicing and isolation of novel splice variants. Premraj A; Nautiyal B; Aleyas AG; Rasool TJ Mol Immunol; 2015 Oct; 67(2 Pt B):357-68. PubMed ID: 26190308 [TBL] [Abstract][Full Text] [Related]
22. Alternative splicing after gene duplication drives CEACAM1-paralog diversification in the horse. Mißbach S; Aleksic D; Blaschke L; Hassemer T; Lee KJ; Mansfeld M; Hänske J; Handler J; Kammerer R BMC Evol Biol; 2018 Mar; 18(1):32. PubMed ID: 29544443 [TBL] [Abstract][Full Text] [Related]
23. Long-read transcriptome sequencing reveals abundant promoter diversity in distinct molecular subtypes of gastric cancer. Huang KK; Huang J; Wu JKL; Lee M; Tay ST; Kumar V; Ramnarayanan K; Padmanabhan N; Xu C; Tan ALK; Chan C; Kappei D; Göke J; Tan P Genome Biol; 2021 Jan; 22(1):44. PubMed ID: 33482911 [TBL] [Abstract][Full Text] [Related]
24. A novel splice variant of XIAP-associated factor 1 (XAF1) is expressed in peripheral blood containing gastric cancer-derived circulating tumor cells. Hatakeyama K; Yamakawa Y; Fukuda Y; Ohshima K; Wakabayashi-Nakao K; Sakura N; Tanizawa Y; Kinugasa Y; Yamaguchi K; Terashima M; Mochizuki T Gastric Cancer; 2015 Oct; 18(4):751-61. PubMed ID: 25216542 [TBL] [Abstract][Full Text] [Related]
25. Identification of an alternative splicing isoform of chicken Lmbr1. Huang Y; Chen W; Li N; Deng X; Kang X; Liu X Mol Biol Rep; 2011 Oct; 38(7):4397-403. PubMed ID: 21161408 [TBL] [Abstract][Full Text] [Related]
27. Altered splicing of CEACAM1 in breast cancer: identification of regulatory sequences that control splicing of CEACAM1 into long or short cytoplasmic domain isoforms. Gaur S; Shively JE; Yen Y; Gaur RK Mol Cancer; 2008 May; 7():46. PubMed ID: 18507857 [TBL] [Abstract][Full Text] [Related]
28. Carcinoembryonic antigen-related cell adhesion molecule 1 expression and signaling in human, mouse, and rat leukocytes: evidence for replacement of the short cytoplasmic domain isoform by glycosylphosphatidylinositol-linked proteins in human leukocytes. Singer BB; Scheffrahn I; Heymann R; Sigmundsson K; Kammerer R; Obrink B J Immunol; 2002 May; 168(10):5139-46. PubMed ID: 11994468 [TBL] [Abstract][Full Text] [Related]
29. Novel transcripts of fibroblast growth factor receptor 3 reveal aberrant splicing and activation of cryptic splice sequences in colorectal cancer. Jang JH; Shin KH; Park YJ; Lee RJ; McKeehan WL; Park JG Cancer Res; 2000 Aug; 60(15):4049-52. PubMed ID: 10945607 [TBL] [Abstract][Full Text] [Related]
30. Characterizing CEACAM5 interaction with CD8α and CD1d in intestinal homeostasis. Roda G; Jianyu X; Park MS; DeMarte L; Hovhannisyan Z; Couri R; Stanners CP; Yeretssian G; Mayer L Mucosal Immunol; 2014 May; 7(3):615-24. PubMed ID: 24104458 [TBL] [Abstract][Full Text] [Related]
31. Five novel alternatively spliced transcripts of DNA (cytosine-5) methyltransferase 2 in human peripheral blood leukocytes. Franchina M; Hooper J; Kay PH Int J Biochem Cell Biol; 2001 Nov; 33(11):1104-15. PubMed ID: 11551826 [TBL] [Abstract][Full Text] [Related]
32. Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis. Beauchemin N; Arabzadeh A Cancer Metastasis Rev; 2013 Dec; 32(3-4):643-71. PubMed ID: 23903773 [TBL] [Abstract][Full Text] [Related]
33. [Identification and expression analysis of a novel splice variant of human tumor necrosis factor receptor associated factor 2]. Luo HY; Zhang B; Yan J; Li L; Yin KK; Han M Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Nov; 27(11):1176-9. PubMed ID: 22078441 [TBL] [Abstract][Full Text] [Related]
34. Species-specific evolution of immune receptor tyrosine based activation motif-containing CEACAM1-related immune receptors in the dog. Kammerer R; Popp T; Härtle S; Singer BB; Zimmermann W BMC Evol Biol; 2007 Oct; 7():196. PubMed ID: 17945019 [TBL] [Abstract][Full Text] [Related]
35. CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids. Gonzalez-Exposito R; Semiannikova M; Griffiths B; Khan K; Barber LJ; Woolston A; Spain G; von Loga K; Challoner B; Patel R; Ranes M; Swain A; Thomas J; Bryant A; Saffery C; Fotiadis N; Guettler S; Mansfield D; Melcher A; Powles T; Rao S; Watkins D; Chau I; Matthews N; Wallberg F; Starling N; Cunningham D; Gerlinger M J Immunother Cancer; 2019 Apr; 7(1):101. PubMed ID: 30982469 [TBL] [Abstract][Full Text] [Related]
36. The Monoclonal Antibody NEO-201 Enhances Natural Killer Cell Cytotoxicity Against Tumor Cells Through Blockade of the Inhibitory CEACAM5/CEACAM1 Immune Checkpoint Pathway. Fantini M; David JM; Annunziata CM; Morelli MP; Arlen PM; Tsang KY Cancer Biother Radiopharm; 2020 Apr; 35(3):190-198. PubMed ID: 31928422 [No Abstract] [Full Text] [Related]
37. Several members of the mouse carcinoembryonic antigen-related glycoprotein family are functional receptors for the coronavirus mouse hepatitis virus-A59. Dveksler GS; Dieffenbach CW; Cardellichio CB; McCuaig K; Pensiero MN; Jiang GS; Beauchemin N; Holmes KV J Virol; 1993 Jan; 67(1):1-8. PubMed ID: 8380065 [TBL] [Abstract][Full Text] [Related]
38. Carcinoembryonic antigens: alternative splicing accounts for the multiple mRNAs that code for novel members of the carcinoembryonic antigen family. Barnett TR; Kretschmer A; Austen DA; Goebel SJ; Hart JT; Elting JJ; Kamarck ME J Cell Biol; 1989 Feb; 108(2):267-76. PubMed ID: 2537311 [TBL] [Abstract][Full Text] [Related]
39. CEACAM5 and CEACAM6 are major target genes for Smad3-mediated TGF-beta signaling. Han SU; Kwak TH; Her KH; Cho YH; Choi C; Lee HJ; Hong S; Park YS; Kim YS; Kim TA; Kim SJ Oncogene; 2008 Jan; 27(5):675-83. PubMed ID: 17653079 [TBL] [Abstract][Full Text] [Related]
40. CEA mRNA identification in peripheral blood is feasible for colorectal, but not for gastric or pancreatic cancer staging. Piva MG; Navaglia F; Basso D; Fogar P; Roveroni G; Gallo N; Zambon CF; Pedrazzoli S; Plebani M Oncology; 2000 Nov; 59(4):323-8. PubMed ID: 11096345 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]